Display options
Cite
Karvellas CJ, Speiser JL, Tremblay M, et al. The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study. Ann Intensive Care. 2017;7(1):99doi: 10.1186/s13613-017-0323-0.
Karvellas, C. J., Speiser, J. L., Tremblay, M., Lee, W. M., Rose, C. F. (2017). The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study. Annals of intensive care, 7(1), 99. https://doi.org/10.1186/s13613-017-0323-0
Karvellas, Constantine J, et al. "The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study." Annals of intensive care vol. 7,1 (2017): 99. doi: https://doi.org/10.1186/s13613-017-0323-0
Karvellas CJ, Speiser JL, Tremblay M, Lee WM, Rose CF. The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study. Ann Intensive Care. 2017 Oct 05;7(1):99. doi: 10.1186/s13613-017-0323-0. PMID: 28983815; PMCID: PMC5629189.
Copy Download .nbib Format: NLM
Share it on

Ann Intensive Care. 2017 Oct 05;7(1):99. doi: 10.1186/s13613-017-0323-0.

The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study.

Annals of intensive care

Constantine J Karvellas, Jaime L Speiser, Mélanie Tremblay, William M Lee, Christopher F Rose,

Affiliations

  1. Division of Gastroenterology (Liver Unit), Department of Critical Care Medicine, University of Alberta, 1-40 Zeidler Ledcor Building, Edmonton, AB, T6G-2X8, Canada. [email protected].
  2. Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  3. Hepato-Neuro Laboratory, CRCHUM, Université de Montréal, Montreal, Canada.
  4. Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

PMID: 28983815 PMCID: PMC5629189 DOI: 10.1186/s13613-017-0323-0

Abstract

BACKGROUND: Acetaminophen (APAP)-induced acute liver failure (ALF) is associated with significant mortality due to intracranial hypertension (ICH), a result of cerebral edema (CE) and astrocyte swelling. Brain-type fatty acid-binding protein (FABP7) is a small (15 kDa) cytoplasmic protein abundantly expressed in astrocytes. The aim of this study was to determine whether serum FABP7 levels early (day 1) or late (days 3-5) level were associated with 21-day mortality and/or the presence of ICH/CE in APAP-ALF patients.

METHODS: Serum samples from 198 APAP-ALF patients (nested case-control study with 99 survivors and 99 non-survivors) were analyzed by ELISA methods and assessed with clinical data from the US Acute Liver Failure Study Group (ALFSG) Registry (1998-2014).

RESULTS: APAP-ALF survivors had significantly lower serum FABP7 levels on admission (147.9 vs. 316.5 ng/ml, p = 0.0002) and late (87.3 vs. 286.2 ng/ml, p < 0.0001) compared with non-survivors. However, a significant association between 21-day mortality and increased serum FABP7 early [log FABP7 odds ratio (OR) 1.16, p = 0.32] and late (log FABP7 ~ OR 1.34, p = 0.21) was not detected after adjusting for significant covariates (MELD, vasopressor use). Areas under the receiver-operating curve for early and late multivariable models were 0.760 and 0.892, respectively. In a second analysis, patients were grouped based on the presence (n = 46) or absence (n = 104) of ICH/CE. A significant difference in FABP7 levels between patients with or without ICH/CE at early (259.7 vs. 228.2 ng/ml, p = 0.61) and late (223.8 vs. 192.0 ng/ml, p = 0.19) time points was not identified.

CONCLUSION: Serum FABP7 levels were significantly elevated at early and late time points in APAP-ALF non-survivors compared to survivors. However, significant differences in FABP7 levels by 21-day mortality were not ascertained after adjusting for significant covariates (reflecting severity of illness). Our study suggests that FABP7 may not discriminate between patients with or without intracranial complications.

Keywords: ALFSG index; Liver-type fatty acid-binding protein; Multiorgan failure; Prognosis

References

  1. Ann Intern Med. 2016 Jun 7;164(11):724-32 - PubMed
  2. Lancet. 1993 Sep 18;342(8873):743 - PubMed
  3. J Neurol. 2005 Jun;252(6):718-24 - PubMed
  4. Eur J Gastroenterol Hepatol. 1999 Sep;11(9):977-84 - PubMed
  5. J Hepatol. 1999 Oct;31(4):771-6 - PubMed
  6. Hepatology. 1994 Jan;19(1):80-7 - PubMed
  7. Hepatology. 2001 Feb;33(2):464-70 - PubMed
  8. Hepatology. 2005 Dec;42(6):1364-72 - PubMed
  9. Science. 1977 Mar 25;195(4284):1356-8 - PubMed
  10. World J Gastroenterol. 2013 Dec 28;19(48):9240-55 - PubMed
  11. Eur J Neurosci. 2006 Jul;24(1):175-87 - PubMed
  12. Hepatology. 2007 Dec;46(6):1679-81 - PubMed
  13. Liver Transpl. 2001 Nov;7(11):964-70 - PubMed
  14. Am J Epidemiol. 2004 Mar 15;159(6):603-10 - PubMed
  15. Crit Care. 2014 Apr 24;18(2):220 - PubMed
  16. Crit Care Med. 2014 May;42(5):1157-67 - PubMed
  17. Int J Cancer. 2001 Nov;94(4):586-90 - PubMed
  18. BMJ. 2007 Oct 20;335(7624):806-8 - PubMed
  19. Lancet. 1993 Jul 31;342(8866):273-5 - PubMed
  20. Hepatology. 1994 Jun;19(6):1407-13 - PubMed
  21. Clin Chem Lab Med. 2005;43(8):802-9 - PubMed
  22. J Hepatol. 1995 Aug;23 (2):212-7 - PubMed
  23. Hepatology. 2017 Mar;65(3):938-949 - PubMed
  24. Neurochem Int. 2012 Jun;60(7):662-71 - PubMed
  25. Eur J Neurol. 2011 Jun;18(6):865-71 - PubMed
  26. Stroke. 1999 Jun;30(6):1190-5 - PubMed
  27. Gastroenterology. 1989 Aug;97(2):439-45 - PubMed
  28. Liver Transpl. 2003 Aug;9(8):887-8 - PubMed
  29. Hepatology. 2007 Dec;46(6):1844-52 - PubMed
  30. Gastroenterol Res Pract. 2013;2013:841707 - PubMed
  31. Hepatology. 1987 Nov-Dec;7(6):1272-7 - PubMed
  32. Hepatology. 1989 Jan;9(1):12-21 - PubMed
  33. J Neurochem. 1996 Apr;66(4):1648-56 - PubMed
  34. Prog Lipid Res. 1996 Sep;35(3):243-82 - PubMed
  35. Hepatology. 1997 Apr;25(4):837-9 - PubMed
  36. J Hepatol. 2006 Jun;44(6):1105-14 - PubMed

Publication Types